Basel Medical Group Ltd
BMGLDrugs in Pipeline
18
Phase 3 Programs
5
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Vitamin D3
Improve Healthy Ageing in Seniors; Prevent Disease at Older Age
Colchicine
Atrial Fibrillation
Paclitaxel dosing according to SmPC
Carcinoma, Non-Small-Cell Lung
Celestamine®
Community-acquired Pneumonia
High-dose influenza vaccine
Influenza
CHILD-IVITAB
Scabies
Dapansutrile
Diabetes Mellitus, Type 2
Cinacalcet
Memory Functions
Salbutamol
Memory Functions
Fampridine SR
Working Memory
Conestat alfa
Acute Kidney Injury
High ribavirin dose
Chronic Hepatitis C
PQR309
Lymphoma
N-TEC
Patellofemoral Osteoarthritis
LSD
Major Depressive Disorder
Interferon beta-1b group
Relapsing-remitting Multiple Sclerosis
Interferon beta 1b
Multiple Sclerosis
Vortioxetine
Glioblastoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Vitamin D3 | Phase 3 | Improve Healthy Ageing in Seniors; Prevent Disease at Older Age | - | - |
Colchicine | Phase 3 | Atrial Fibrillation | - | - |
Paclitaxel dosing according to SmPC | Phase 3 | Carcinoma, Non-Small-Cell Lung | - | - |
Celestamine® | Phase 3 | Community-acquired Pneumonia | - | - |
High-dose influenza vaccine | Phase 3 | Influenza | - | - |
CHILD-IVITAB | Phase 2 | Scabies | - | - |
Dapansutrile | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
Cinacalcet | Phase 2 | Memory Functions | - | - |
Salbutamol | Phase 2 | Memory Functions | - | - |
Fampridine SR | Phase 2 | Working Memory | - | - |
Conestat alfa | Phase 2 | Acute Kidney Injury | - | - |
High ribavirin dose | Phase 2 | Chronic Hepatitis C | - | - |
PQR309 | Phase 2 | Lymphoma | - | - |
N-TEC | Phase 2 | Patellofemoral Osteoarthritis | - | - |
LSD | Phase 2 | Major Depressive Disorder | - | - |
Interferon beta-1b group | Phase 2 | Relapsing-remitting Multiple Sclerosis | - | - |
Interferon beta 1b | Phase 2 | Multiple Sclerosis | - | - |
Vortioxetine | Phase 2 | Glioblastoma | - | - |
Frequently asked questions
What is in Basel Medical Group Ltd's drug pipeline?→
CatalystAlert tracks 18 drug candidates in Basel Medical Group Ltd's (BMGL) pipeline across Phase 3, Phase 2. Its lead program is Vitamin D3 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Basel Medical Group Ltd's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Basel Medical Group Ltd (BMGL) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track BMGL biotech catalysts?→
Add BMGL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Basel Medical Group Ltd's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.